Funding awarded
- A Phase II Study of Inhaled CO for the Treatment of ARDS awarded by United States Department of Defense Principal Investigator 2018 - 2025
- A Phase 1b Study of Inhaled CO for the Treatment of Sepsis-Induced ARDS awarded by National Heart, Lung, & Blood Institute Co-Investigator 2020 - 2025